Rationale: Long-term outcomes of patients with coronavirus disease (COVID-19)–related
acute respiratory distress syndrome treated with extracorporeal membrane oxygenation …

Extracorporeal membrane oxygenation (ECMO) has been used in highly selected COVID-19
patients with severe respiratory failure. Scarce data exist on long-term outcomes of these …

Background Critical illness from COVID-19 is associated with prolonged hospitalization and
high mortality rates. Extracorporeal membrane oxygenation is used for refractory severe …

Objective We sought to determine the influence of venovenous extracorporeal membrane
oxygenation (ECMO) on outcomes of mechanically ventilated patients with COVID-19 during …

Objectives: To prospectively describe 1-year outcomes, with a focus on functional outcome,
cognitive outcome, and the burden of anxiety, depression, and post-traumatic stress …

An increased need of extracorporeal membrane oxygenation (ECMO) support is going to
become evident as treatment of SARS-CoV-2 respiratory distress syndrome. This is the first …

Background Extracorporeal membrane oxygenation (ECMO) has been widely used in
patients with COVID-19, but uncertainty remains about the determinants of in-hospital …

Background The value of extracorporeal membrane oxygenation (ECMO) for patients
suffering from novel coronavirus disease 2019 (COVID-19) as a rescue therapy for …

Background: The use of extracorporeal membrane oxygenation (ECMO) in coronavirus
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …

OBJECTIVES: To compare complications and mortality between patients that required
extracorporeal membrane oxygenation (ECMO) support for acute respiratory distress …